CS logo
small CS logo
Lexmedica

Wroclaw, Poland
Instytut badawczy we Wrocławiu

About Lexmedica


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Shire
11
Celgene
9
Pfizer
9
Hoffmann-La Roche
7
Takeda
5
Ferring Pharmaceuticals
3
Abivax S.A.
2
Eli Lilly and Company
2
Bristol-Myers Squibb
1
Gilead Sciences
1
sigma-tau i.f.r. S.p.A.
1
Total Rows: 11

Clinical Trials at Lexmedica


During the past decade, Lexmedica conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 31 clinical trials were completed, i.e. on average, 93.9% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 20 clinical trials were completed. i.e. 2000% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1010443310105511001144224444Started TrialsCompleted Trails201520162017201820192020051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Trial of Degarelix in Patients With Prostate Cancer
2009-06-01
2011-03-01
Completed
859
Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis
2010-06-29
2012-12-07
Completed
759
Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease
2011-04-06
2015-10-09
Completed
265
A Study To Monitor Long-Term Treatment With PF-00547659
2011-07-01
2016-07-27
Completed
268
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
2012-07-20
2016-05-27
Completed
593
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
2012-04-01
2015-05-01
Completed
614
Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
2012-10-01
2020-08-06
Completed
944
Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)
2012-02-27
2013-05-14
Completed
480

Rows per page:

1–51 of 51

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Lexmedica" #1 sponsor was "Shire" with 11 trials, followed by "Celgene" with 9 trials sponsored, "Pfizer" with 9 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored and "Takeda" with 7 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Lexmedica" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsShire: 11Shire: 11Celgene: 9Celgene: 9Pfizer: 9Pfizer: 9Hoffmann-La Roche: 7Hoffmann-La Roche: 7Takeda: 5Takeda: 5Ferring Pharmaceuticals: 3Ferring Pharmaceuticals: 3Abivax S.A.: 2Abivax S.A.: 2Eli Lilly and Company: 2Eli Lilly and Company: 2Bristol-Myers Squibb: 1Bristol-Myers Squibb: 1Gilead Sciences: 1Gilead Sciences: 1

Created with Highcharts 11.1.0Top CollaboratorsArena is a whollyowned subsidiary ofPfizer: 1Arena is a whollyowned subsidiary ofPfizer: 1Astellas Pharma Inc: 1Astellas Pharma Inc: 1Medivation LLC, awholly ownedsubsidiary of Pfizer Inc.:1Medivation LLC, awholly ownedsubsidiary of Pfizer Inc.:1PRA Health Sciences: 1PRA Health Sciences: 1

Clinical Trials Conditions at Lexmedica


According to Clinical.Site data, the most researched conditions in "Lexmedica" are "Ulcerative Colitis" (26 trials), "Crohn's Disease" (9 trials), "Crohn Disease" (7 trials), "Colitis, Ulcerative" (5 trials) and "Prostate Cancer" (2 trials). Many other conditions were trialed in "Lexmedica" in a lesser frequency.

Clinical Trials Intervention Types at Lexmedica


Most popular intervention types in "Lexmedica" are "Drug" (50 trials), "Other" (8 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (26 trials), "Etrolizumab" (5 trials), "Ontamalimab" (4 trials), "Ozanimod" (4 trials) and "GED-0301" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Lexmedica


The vast majority of trials in "Lexmedica" are 49 trials for "All" genders and 2 trials for "Male" genders.

Clinical Trials Status at Lexmedica


Currently, there are NaN active trials in "Lexmedica". undefined are not yet recruiting, 6 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Lexmedica, undefined suspended trials, and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Lexmedica, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 35Phase 3: 35Phase 2: 14Phase 2: 14Phase 4: 2Phase 4: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 27Completed: 27Active, not recruiting: 10Active, not recruiting: 10Terminated: 7Terminated: 7Recruiting: 6Recruiting: 6Withdrawn: 1Withdrawn: 1